Form 4: Arteris CFO Nicholas B. Hawkins Sells 722 Shares Under 10b5-1 Trading Plan

Arteris, Inc.'s CFO, Nicholas B. Hawkins, sold 722 shares of common stock at $9.30 per share on December 5, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, the VP and Chief Financial Officer of Arteris, Inc., sold 722 shares of the company's common stock on December 5, 2024.
• The sale was executed at a price of $9.30 per share.
• This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted by Mr. Hawkins on May 20, 2024.
• Following the transaction, Mr. Hawkins directly owns 184,255 shares of Arteris common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine disclosure of an insider stock sale, which is common for executives of publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, such as those in the technology sector like Arteris.
• Similar filings are regularly seen from executives at companies like Cadence Design Systems (CDNS) and Synopsys (SNPS), which are also in the electronic design automation space.
• The volume of shares sold is relatively small compared to the total shares outstanding, which is typical for routine sales under 10b5-1 plans.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders as it is a small transaction by an individual executive under a pre-arranged plan.

Key Dates

Keywords

Arteris, insider trading, Form 4, Nicholas B. Hawkins, 10b5-1 trading plan, stock sale, executive compensation, AIP